期刊簡介預計審稿時間： 4 Weeks

The Journal of Kidney Cancer and VHL is a peer-reviewed online open access journal that focuses on disseminating research findings on kidney cancer and Von Hippel Lindau disease. Renal cell carcinoma, also known as renal cell carcinoma, accounts for approximately 2% of all cancers, and abnormalities in the VHL gene are the main risk factor for the development of renal cell carcinoma. VHL abnormalities can also lead to another rare disease, VHL syndrome, whose incidence rate is estimated to be 1/36000.

This journal aims to become an academic forum for academic exchange, enabling scientists to develop better treatment strategies for these two diseases. The Journal of Kidney Cancer and VHL publishes basic scientific and clinical research articles on all aspects of kidney cancer and VHL, including original articles, reviews, case reports, brief communications, and letters to editors, and is suitable for submission.

《腎癌與VHL雜志》是一本同行評審的在線開放獲取期刊，專注于傳播腎癌和VHL（Von Hippel-Lindau）疾病的研究成果。腎癌，也稱為腎細胞癌，約占所有癌癥的2%，而VHL基因的異常是腎癌發(fā)展的主要風險因素。VHL異常也會導致另一種罕見病——VHL綜合征，其發(fā)病率估計為1/36000 。

該期刊旨在成為一個學術交流的學術論壇，使科學家能夠為這兩種疾病開發(fā)更好的治療策略。《腎癌與VHL雜志》發(fā)表關于腎癌和VHL的所有方面的基礎科學和臨床研究文章，包括原創(chuàng)文章、綜述、病例報告、簡短通訊和給編輯的信件等類型的文章，適合提交 。

如果您需要協(xié)助投稿或潤稿服務，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務十年，熟悉發(fā)表政策，可為您提供一對一投稿指導，避免您在投稿時頻繁碰壁，節(jié)省您的寶貴時間，有效提升發(fā)表機率，確保SCI檢索（檢索不了全額退款）。我們視信譽為生命，多方面確保文章安全保密，在任何情況下都不會泄露您的個人信息或稿件內容。